Patient-Specific 3D Action Observation Training in Parkinson's Disease
Examining the Effect of Action Observation Training Using Patient-Specific 3D Records in Parkinson's Patients
1 other identifier
interventional
24
1 country
1
Brief Summary
Although studies exist demonstrating the effects of single-session action observation training on bradykinesia in patients with Parkinson's disease, research investigating the long-term application of such training remains limited. Furthermore, the broader literature indicates that action observation training has typically been conducted in simulated environments or by using recordings obtained from healthy individuals. The aim of the present study is to examine the effects of action observation training, delivered in a fully immersive virtual reality environment using each patient's own 3D motion recordings, on bradykinesia and other disease-related parameters.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable parkinson-disease
Started Dec 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 2, 2025
CompletedFirst Posted
Study publicly available on registry
November 26, 2025
CompletedStudy Start
First participant enrolled
December 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 15, 2027
November 26, 2025
October 1, 2025
1.6 years
October 2, 2025
November 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Spontaneous Movement Rate (SMR
In this study, kinematic parameters of finger movements will be determined from video recordings. A commercial motion analysis software will be used to extract the coordinates of manually marked tracking points, which will then be transferred into tabular form for analysis. To improve the accuracy of marking and tracking, participants will wear fingertip gloves in different colors.The spontaneous movement rate will be calculated from video-recorded finger-tapping tasks. Each cycle consists of a touch duration (TD) and an inter-tapping interval (ITI). SMR will be defined as the inverse of the total duration of one tapping cycle (TD + ITI) and expressed in Hertz (Hz).
At baseline and after completion of 6-week intervention period
Secondary Outcomes (5)
Unified Parkinson's Disease Rating Scale (UPDRS)
At baseline and after completion of 6-week intervention period
Nine-Hole Peg Test (NHPT)
At baseline and after completion of 6-week intervention period
Disabilities of the Arm, Shoulder and Hand Questionnaire (DASH)
At baseline and after completion of 6-week intervention period
Parkinson's Disease Questionnaire (PDQ-8)
At baseline and after completion of 6-week intervention period
Intrinsic Motivation Inventory (IMI)
After completion of 6-week intervention period
Study Arms (2)
Patient-Specific VR Group
EXPERIMENTALParticipants will undergo action observation training delivered in immersive virtual reality using their own 3D motion recordings.
Healthy-Model VR Group
ACTIVE COMPARATORParticipants will undergo action observation training delivered in immersive virtual reality using 3D recordings obtained from healthy individuals performing the same actions.
Interventions
Participants will receive immersive VR action observation training using their own 3D motion recordings captured with an Insta360 camera (Arashi Vision Inc., Shenzhen, China). In Parkinson's patients, only the initial movement sequences without bradykinetic slowing will be selected, and these will be extended to the desired duration using loop playback or ping-pong loop playback in the device's proprietary software. The action observation protocol will consist of the following one-minute tasks: (1) total finger abduction and adduction, (2) fist making and opening, (3) wrist flexion and extension, (4) forearm pronation and supination, and (5) rhythmic striking of the dorsal and palmar surfaces of one hand against the palm of the other. A 1-minute rest will be given between each video. Training will be provided in addition to conventional therapy (35 minutes, 3 days per week for 6 weeks) tailored to individual needs.
Participants will receive immersive VR action observation training using 3D video recordings of the same activities performed by healthy individuals, captured with an Insta360 camera (Arashi Vision Inc., Shenzhen, China). Recordings will not require editing or adjustments. The action observation protocol will consist of the same one-minute tasks: (1) total finger abduction and adduction, (2) fist making and opening, (3) wrist flexion and extension, (4) forearm pronation and supination, and (5) rhythmic striking of the dorsal and palmar surfaces of one hand against the palm of the other. A 1-minute rest will be given between each video. Training will be provided in addition to conventional therapy (35 minutes, 3 days per week for 6 weeks) tailored to individual needs.
Eligibility Criteria
You may qualify if:
- Voluntary agreement to participate in the study
- Clinical diagnosis of Parkinson's disease confirmed by a neurologist
- Ongoing treatment with antiparkinsonian medication
- Hoehn and Yahr (H-Y) stage ≤ 3
- Ability to walk independently
You may not qualify if:
- Presence of additional neurological disorders other than Parkinson's disease
- Change in medication dosage within the past month
- Score of ≥ 10 on the Simulator Sickness Questionnaire
- Presence of amblyopia, strabismus, or pathologies impairing focus, depth perception, or normal 3D vision
- Failure on the butterfly test of the Titmus stereotest (greater than 3,552 seconds of arc)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Abant Izzet Baysal University Faculty of Health Science
Bolu, Bolu, 14100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Only the outcome assessor will be masked to group allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 2, 2025
First Posted
November 26, 2025
Study Start
December 15, 2025
Primary Completion (Estimated)
July 15, 2027
Study Completion (Estimated)
August 15, 2027
Last Updated
November 26, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share
No, individual participant data (IPD) will not be made available to other researchers.